Physician

Alice Kavitha David, M.D.

According to 2025 Medicare claims, Alice David, M.D. (NPI: 1780661066) practices hematology/oncology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES PC (NPI: 1912917824; TIN: 581481590) and primary practice location at 30909-6520.

David's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,076 traditional Medicare patients, billed 259,294 HCPCS/CPT codes, and received $3,638,181 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,394 prescription claims across 376 beneficiaries totaling $1,574,860 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 16 claims. Open Payments data shows 185 records totaling $13,696. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,239,886 to $3,638,181. Similarly, Part D prescription costs have risen steadily, from $722,319 to $1,574,860. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	718	118,848	$1,239,886
2016	797	111,989	$1,479,447
2017	837	155,392	$1,812,787
2018	977	193,161	$1,775,748
2019	1,010	212,185	$2,881,425
2020	961	221,991	$2,957,494
2021	1,073	247,625	$3,424,269
2022	1,146	270,603	$3,262,728
2023	1,201	294,736	$3,878,196
2024	1,076	259,294	$3,638,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	278	1,483	$722,319
2016	278	1,567	$1,023,856
2017	308	1,544	$998,496
2018	387	1,695	$1,380,342
2019	381	1,793	$1,545,821
2020	328	1,606	$1,181,105
2021	326	1,504	$1,823,036
2022	343	1,427	$1,834,623
2023	394	1,446	$1,410,233
2024	376	1,394	$1,574,860

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	87	$33,004
2016	N/R	96	$27,182
2017	11	100	$18,128
2018	14	58	$6,695
2019	N/R	74	$5,093
2020	N/R	58	$3,171
2021	N/R	28	$2,716
2022	N/R	18	$1,327
2023	N/R	N/R	N/R
2024	N/R	16	$1,476

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	308	529	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	335	426	$57
80053	Blood test, comprehensive group of blood chemicals	754	1,670	$10
36415	Insertion of needle into vein for collection of blood sample	815	1,897	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	794	1,845	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	21	630	$455,828
Lenalidomide	Lenalidomide	34	868	$405,034
Cabometyx	Cabozantinib S-Malate	11	330	$281,051
Eliquis	Apixaban	14	420	$8,371
Anastrozole	Anastrozole	455	31,483	$7,760

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	16	$1,476

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	184	$3,696	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$10,000	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alice Kavitha David, M.D.?

Tedicare shows public-source Medicare data for Alice Kavitha David, M.D. (NPI 1780661066), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alice Kavitha David, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alice Kavitha David, M.D.?

Alice Kavitha David, M.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES PC (billing NPI 1912917824) in the available physician profile data.

Does Alice Kavitha David, M.D. have Open Payments data?

Alice Kavitha David, M.D. has 185 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.